Parkinson's Disease Clinical Trials in Philadelphia

Showing 61-80 of 84 trials

Phase II Subthalamic Nucleus (STN) vs. Globus Pallidus (GPi) Trial

NCT01076452

The goal of the second phase of the study is to determine if simultaneous bilateral subthalamic nucleus stimulation or simultaneous bilateral globus pallidus stimulation is more effective in reducing symptoms of Parkinson's Disease.

Parkinson's Disease

US Department of Veterans Affairs299 participantsStarted Apr 2002

Los Angeles, California, United States • San Francisco, California, United States • San Francisco, California, United States +11 more locations

COMPLETEDPHASE3< 1 mile

Phase I Deep Brain Stimulation (DBS) vs. Best Medical Therapy (BMT) Trial

NCT00056563

The goals of this study are to determine if simultaneous bilateral subthalamic nucleus stimulation or simultaneous bilateral globus pallidus stimulation is more effective in reducing symptoms of Parkinson's disease, and if deep brain stimulation or best medical therapy is more effective in improving Parkinson's disease symptoms

Parkinson's Disease

US Department of Veterans Affairs255 participantsStarted Apr 2002

Los Angeles, California, United States • San Francisco, California, United States • San Francisco, California, United States +11 more locations

Phase II Subthalamic Nucleus (STN) vs. Globus Pallidus (GPi) Trial

Phase I Deep Brain Stimulation (DBS) vs. Best Medical Therapy (BMT) Trial

Parkinson's Disease Trials in Other Cities

Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients

Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa

GM1 Ganglioside Effects on Parkinson's Disease

Study on the Effect of External Magnetic Stimulation on Patients With Parkinson's Disease

Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist

Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch

A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease

A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)

Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD)

PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study of LRRK2 (Leucine-rich Repeat Kinase 2)

Embryonic Dopamine Cell Implants for Parkinson's Disease

Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).

Safety of Urate Elevation in Parkinson's Disease

Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease

A Study of Three Doses of TCH346 in Patients With Early Parkinson's Disease to Evaluate Safety and Efficacy

An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.

Other Conditions in Philadelphia